Literature DB >> 617271

Tissue culture studies of demyelinating disease: a critical review.

F J Seil.   

Abstract

Tissue culture studies of human and experimental demyelinating diseases have demonstrated that sera from patients with multiple sclerosis reversibly demyelinate central nervous system cultures. Similar changes are evoked by sera from animals with experimental allergic encephalomyelitis induced by inoculation with whole central nervous system tissue but not by encephalitogenic myelin basic protein. Sera and buffy coat or lymph node cells from humans with idiopathic polyneuritis and animals with experimental allergic neuritis demyelinate cultures of peripheral nervous system tissue. While these studies have contributed to speculations about pathogenetic mechanisms of demyelinating diseases, including the role of both circulating antibodies and delayed hypersensitivity factors, a number of important questions remain unanswered. Among these are the identity of the antigens that evoke antimyelin antibodies and the precise relationship of serum or cellular antimyelin factors to the pathogenesis or clinical course of the demyelinating diseases. Further studies with this technique may provide more complete information about the role of immunological events in induction of disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 617271     DOI: 10.1002/ana.410020417

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Abnormal protein patterns in multiple sclerosis.

Authors:  J Y Wu; K M Welch; C C Duncan
Journal:  Neurochem Res       Date:  1979-12       Impact factor: 3.996

2.  Even in culture, oligodendrocytes myelinate solely axons.

Authors:  C Lubetzki; C Demerens; P Anglade; H Villarroya; A Frankfurter; V M Lee; B Zalc
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 3.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

4.  Demyelination in experimental canine distemper virus infection: immunological, pathologic, and immunohistological studies.

Authors:  M Vandevelde; R J Higgins; B Kristensen; F Kristensen; A J Steck; U Kihm
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors:  S J Owen; C M Watson; A N Davison
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

6.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

Review 7.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

Review 8.  Multiple sclerosis.

Authors:  C M Poser
Journal:  Med Clin North Am       Date:  1979-07       Impact factor: 5.456

9.  Autoimmune and virus-induced demyelinating diseases. A review.

Authors:  P W Lampert
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

10.  Human oligodendrocytes in dissociated cell culture.

Authors:  F Rihs; J Kesselring; C Meier
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.